Life Science gets attention when the Swedish magazines ”Ny Teknik” and ”Affärsvärlden” present the 33 most promising technology companies in Sweden.
Eight of the top 28 biotech companies in Sweden is located within Karolinska Institutet Science Park, this is an acknowledgment that the science park offers a stimulating environment.
On the International level, we congratulate Pål Nyrén, professor at KTH, nominated in European Inventor Awards.
When Veckans Affärer announced their list of the top 28 most promising biotech companies in Sweden, it shows that no less than eight of them is located within in KI Science Park, Stockholm. Märit Johansson, CEO of KI Science Park, see this as a confirmation that the they provide the most productive environment for innovative life science companies. Top placement pinch Index Pharmaceuticals, a biopharmaceutical company developing immunotherapies and diagnostic equipment with focus gastrointestinal problems.
It is clear that life sciences is an exciting sector becomes clearly even in general rankings of companies.
Last week when the 33 most promising technology companies in Sweden was ranked by the Swedish magazines Ny Teknik and Affärsvärlden we found that seven companies within the Life Science sector has found a place.
Anolytech - Environmentally friendly ways to kill bacteria and viruses.
Atlas Antibodies - Custom antibodies.
Biolamina - Human proteins for better cultivation of stem cells.
Biovica - Sensitive blood tests reveal tumor growth.
Excillum - Better X-ray lab and industry.
Q-linea - Rapid identification of pathogens.
Trialbee - Patient recruitment via the Web.
Swedish top research result in good products.
Pål Nyrén, professor at KTH in Biochemistry, is nominated for European Inventor Award in the category small and medium-sized enterprises. European Inventor Award has nominated 15 scientists and engineers for their contributions to the technical, social and economic progress
Pål Nyrén, professor at KTH Royal Institute of Technology, and his team invented pyrosequencing ─ a far faster, less complicated and cheaper method to sequence DNA strands. The combined advantages of lower costs and greater speeds has revolutionized the study of the building blocks of life, and is giving researchers new avenues for pursuing personalised treatments and cures for life-threatening diseases such as cancer. (writes epo.org ) The technology is available on the market since a couple of years by Qiagen, and 454 Life Sciences.
Read more